Table: Brightpath Biotherapeutics -Q1 group results

BrightPath Biotherapeutics Co

14/08/2017 07:00

Aug 14 (Reuters)-  
             Brightpath Biotherapeutics Co., Ltd.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended        Year to   
                Jun 30, 2017        Jun 30, 2016      Mar 31, 2018   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            90 mln                                280 mln     
                                                       (-47.1 pct)   
  Operating     loss 262 mln                            loss 2.00    
  Recurring     loss 262 mln                            loss 2.00    
  Net           loss 263 mln                            loss 2.00    
  EPS           loss 7.08 yen                        loss 53.73 yen  
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
   
  NOTE - Brightpath Biotherapeutics Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T  
  ((Tokyo Headline News Desk +813 6441 1812))